Investors Buy Large Volume of iShares Biotechnology ETF Put Options (NASDAQ:IBB)

iShares Biotechnology ETF (NASDAQ:IBB) was the recipient of unusually large options trading on Friday. Stock traders purchased 72,977 put options on the company. This represents an increase of approximately 1,643% compared to the typical volume of 4,188 put options.

Hedge Funds Weigh In On iShares Biotechnology ETF

Hedge funds and other institutional investors have recently made changes to their positions in the company. Park Avenue Securities LLC acquired a new stake in iShares Biotechnology ETF during the 3rd quarter valued at approximately $218,000. Royal Fund Management LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth about $1,304,000. Capital Insight Partners LLC lifted its stake in shares of iShares Biotechnology ETF by 5.4% in the 3rd quarter. Capital Insight Partners LLC now owns 14,431 shares of the financial services provider’s stock valued at $2,101,000 after purchasing an additional 739 shares during the period. Albion Financial Group UT boosted its position in shares of iShares Biotechnology ETF by 0.3% during the 3rd quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock valued at $18,925,000 after purchasing an additional 356 shares in the last quarter. Finally, Valeo Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF during the third quarter worth approximately $206,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 1.8 %

Shares of iShares Biotechnology ETF stock traded down $2.57 on Friday, reaching $137.99. 1,196,913 shares of the company were exchanged, compared to its average volume of 1,477,423. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The company has a 50-day moving average of $136.29 and a 200 day moving average of $141.47.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.